Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site.

FY19 Result – Is The Synlait (ASX:SM1) Share Price A Buy?

Synlait Milk Ltd (ASX:SM1) has reported its result for the year to 31 July 2019, is the share price a buy?

Synlait Milk Ltd (ASX: SM1) has reported its result for the year to 31 July 2019, is the share price a buy?

Synlait Milk is a New Zealand based dairy processing company which produces a range of milk and milk powder related products such as infant formula. Synlait also has exclusive supply rights for The a2 Milk Company Limited’s (ASX: A2M) canned infant formula products in the Australia/New Zealand and China markets. As of March 2019, a2 Milk was a 17.4% shareholder of Synlait.

Synlait’s FY19 Report

The dairy business reported that its revenue increased by 17% to NZ$1.02 billion, exceeding NZ$1 billion for the first time.

Sales volume increased by 16% to 149,730 MT and the average milk price was $6.58 per kgMS for the 2018/19 season, made up of a base milk price of $6.40 and an additional $0.18 in incentive payments.

Consumer packaged infant formula volumes continue to grow at a good pace, increasing by 21% to 42,907 MT.

Net profit increased by 10% to NZ$82.2 million. Consensus market expectations had been for a net profit of NZ$88 million, so the company seems to have underperformed to expectations with its result.

Synlait’s expenditure increase was in line with its gross profit growth, but the company explained a lot of this investment in areas that support future opportunities.

During FY19 its growth projects included: the $260 million build of Synlait’s new infant-capable manufacturing facility in Pokeno which is close to commissioning, the $18.9 million expansion of its lactoferrin facility to double manufacturing capacity, the $134 million advanced liquid dairy packaging facility at Dunsandel was designed, built and commissioned in 18 months, and the Talbot Forest Cheese Acquisition was completed on 1 August 2019.

Is The Synlait Share Price A Buy?

Regarding the court case about the Pokeno facility, Synlait said that it’s comfortable that the legal exposure is not substantial.

In FY20 the company expects continued consumer packaged infant formula momentum, a full year operationof its advanced liquid dairy packaging facility and the first sales of long-long products in the second half of FY20 and contributions from its other facilities.

It expects profit growth in FY20 to be at least similar to this year’s (10%), so the further growth is a good compounding effect.

Synlait is making plenty of progress, particularly from its investing. But I’d probably say I’m more attracted to the idea of buying shares of A2 Milk rather Synlait itself.

Even better than Synlait and A2 Milk, the growth shares in the brand new free report below could deliver very good results over the next few years.

[ls_content_block id=”14947″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content